Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The goal of this observational study is to find the diagnostic biomarkers in serum and urine from early breast cancer patients. The main questions it aims to answer are:
Participants, including breast and non-breast cancer patients will be asked to provides blood and urine during their diagnosis and treatment process without changing the original treatment. When necessary, specimens will be collected during the surgery,without affecting pathological diagnosis.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Breast cancer patients | No intervention. The patients who are diagnosed as breast cancer by postoperative pathological. |
| |
| Patients with benign breast lesions | No intervention. The patients who are diagnosed asbenign breast lesions by postoperative pathological. |
| |
| Healthy population | No intervention. The volunteers. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Collect blood and urine,pathological specimens if necessary | Diagnostic Test | Use EDTA anticoagulant pipe to collect all blood 2ml, and collect 3ml of urine with sterile test tube |
| Measure | Description | Time Frame |
|---|---|---|
| The different biomarkers in malignant and benign breast diseases | By analyzing the differences (eg:PCA, FC and et al.)in the composition of proteins in blood and urine, biomarkers with significant differences between the two groups will be obtained. | It is expected to be one to two years. |
| Diagnostic models used different biomarkers by machine learning | Using biomarkers that detect discrepancies, combined with machine learning to build early breast cancer diagnostic models. | Within half a year after the completion of the test. |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
early breast cancer(Tis,T1-3N0-1M0)
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Jieqiong Liu Ph.D. | Contact | 13922272706 | liujieqiong01@163.com |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Recruiting | Guangzhou | Guangdong | 510120 | China |
Not provided
Not provided
Not provided
Not provided
The blood sample contains DNA, but the measurement does not involve DNA. Once the project is complete, the sample will be properly disposed.